Yancopoulos; George D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yancopoulos; George D..The latest application filed is for "use of a vegf antagonist to treat angiogenic eye disorders".
Company Profile
30.160.181
- Yancopoulos; George D. - Yorktown Heights NY
- Yancopoulos; George D. - Tarrytown NY
- Yancopoulos, George D. - Yoktown Heights NY
- Yancopoulos; George D. - Elmhurst NY
- Yancopoulos; George D. - Briarcliff Manor NY
Patent Activity
| Patent | Date |
|---|---|
| Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof Grant 11,453,721 - Murphy , et al. September 27, 2 | 2022-09-27 |
| Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders App 20220273764 - YANCOPOULOS; George D. | 2022-09-01 |
| Bispecific anti-CD28 .times. anti-CD22 antibodies and uses thereof Grant 11,396,544 - Murphy , et al. July 26, 2 | 2022-07-26 |
| Method of treating an allergy with allergen-specific monoclonal antibodies Grant 11,352,417 - Orengo , et al. June 7, 2 | 2022-06-07 |
| Genetically Modified Mice and Engraftment App 20220000084 - Stevens; Sean ; et al. | 2022-01-06 |
| Targeted Modification Of Rat Genome App 20210301301 - Lee; Jeffrey D. ; et al. | 2021-09-30 |
| Genetically modified mice and engraftment Grant 11,051,499 - Stevens , et al. July 6, 2 | 2021-07-06 |
| High Affinity Human Antibodies To Human Il-4 Receptor App 20210163611 - MARTIN; Joel H. ; et al. | 2021-06-03 |
| Anti-activin A Antibodies And Uses Thereof App 20210163583 - Gromada; Jesper ; et al. | 2021-06-03 |
| Diagnostic Tests And Methods For Assessing Safety, Efficacy Or Outcome Of Allergen-specific Immunotherapy (sit) App 20210148929 - YANCOPOULOS; George D. ; et al. | 2021-05-20 |
| Humanized M-CSF Mice App 20210112791 - Murphy; Andrew J. ; et al. | 2021-04-22 |
| Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Grant 10,975,139 - Babb , et al. April 13, 2 | 2021-04-13 |
| Targeted modification of rat genome Grant 10,975,390 - Lee , et al. April 13, 2 | 2021-04-13 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20210100228 - Flavell; Richard ; et al. | 2021-04-08 |
| Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant 10,954,289 - Babb , et al. March 23, 2 | 2021-03-23 |
| Methods of Treating Inflammatory Conditions App 20210079105 - Orengo; Jamie M. ; et al. | 2021-03-18 |
| Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) Grant 10,935,554 - Yancopoulos , et al. March 2, 2 | 2021-03-02 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20210023173 - YANCOPOULOS; George D. | 2021-01-28 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 10,888,601 - Yancopoulos January 12, 2 | 2021-01-12 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 10,857,205 - Yancopoulos December 8, 2 | 2020-12-08 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 10,828,345 - Yancopoulos November 10, 2 | 2020-11-10 |
| Methods of treating inflammatory conditions Grant 10,815,305 - Orengo , et al. October 27, 2 | 2020-10-27 |
| Isolating Cells Expressing Secreted Proteins App 20200326349 - Fandl; James P. ; et al. | 2020-10-15 |
| Methods And Compositions For Insertion Of Antibody Coding Sequences Into A Safe Harbor Locus App 20200318136 - Wang; Cheng ; et al. | 2020-10-08 |
| Genetically modified non-human animals and methods of use thereof Grant 10,785,968 - Flavell , et al. September 29, 2 | 2020-09-29 |
| Humanized M-CSF mice Grant 10,785,966 - Murphy , et al. September 29, 2 | 2020-09-29 |
| Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant 10,787,501 - Babb , et al. September 29, 2 | 2020-09-29 |
| EGFR x CD28 MULTISPECIFIC ANTIBODIES App 20200299388 - Skokos; Dimitris ; et al. | 2020-09-24 |
| Multivalent Antigen-Binding Proteins App 20200299414 - Yancopoulos; George D. ; et al. | 2020-09-24 |
| Methods And Compositions For The Targeted Modification Of A Genome App 20200291425 - Frendewey; David ; et al. | 2020-09-17 |
| Method Of Treating An Allergy With Allergen-specific Monoclonal Antibodies App 20200255503 - Kind Code | 2020-08-13 |
| Bispecific Anti-cd28 X Anti-cd22 Antibodies And Uses Thereof App 20200239576 - Murphy; Andrew J. ; et al. | 2020-07-30 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20200229410 - Herndler-Brandstetter; Dietmar ; et al. | 2020-07-23 |
| Methods and compositions for the targeted modification of a mouse ES cell genome Grant 10,711,280 - Frendewey , et al. | 2020-07-14 |
| Bispecific Anti-muc16 X Anti-cd28 Antibodies And Uses Thereof App 20200199233 - Murphy; Andrew J. ; et al. | 2020-06-25 |
| Mice that produce hybrid antibodies Grant 10,640,800 - Murphy , et al. | 2020-05-05 |
| B cell lineage based immunogen design with humanized animals Grant 10,626,168 - Haynes , et al. | 2020-04-21 |
| Isolating cells expressing secreted proteins Grant 10,598,669 - Fandl , et al. | 2020-03-24 |
| Mice that produce hybrid antibodies Grant 10,584,364 - Murphy , et al. | 2020-03-10 |
| Genetically modified non-human animals and methods of use thereof Grant 10,561,126 - Herndler-Brandstetter , et al. Feb | 2020-02-18 |
| Genetically modified mice that produce hybrid antibodies Grant 10,526,630 - Murphy , et al. J | 2020-01-07 |
| Anti-activin A antibodies and uses thereof Grant 10,526,403 - Gromada , et al. J | 2020-01-07 |
| Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas App 20200002731 - Frendewey; David ; et al. | 2020-01-02 |
| Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas App 20200002730 - Frendewey; David ; et al. | 2020-01-02 |
| Anti-FGFR1c antibody-FGF21 fusion proteins Grant 10,519,240 - Yancopoulos , et al. Dec | 2019-12-31 |
| Bispecific Anti-psma X Anti-cd28 Antibodies And Uses Thereof App 20190389951 - Murphy; Andrew J. ; et al. | 2019-12-26 |
| Isolating Cells Expressing Secreted Proteins App 20190376981 - Fandl; James P. ; et al. | 2019-12-12 |
| Methods and compositions for targeted genetic modification using paired guide RNAs Grant 10,457,960 - Frendewey , et al. Oc | 2019-10-29 |
| Targeted Modification Of Rat Genome App 20190323032 - Lee; Jeffrey D. ; et al. | 2019-10-24 |
| Genetically Modified Mice and Engraftment App 20190297862 - Stevens; Sean ; et al. | 2019-10-03 |
| Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties Grant 10,392,430 - Papadopoulos , et al. A | 2019-08-27 |
| Targeted modification of rat genome Grant 10,385,359 - Lee , et al. A | 2019-08-20 |
| Methods Of Lowering Blood Glucose Levels App 20190248888 - Kim; Jinrang ; et al. | 2019-08-15 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20190247463 - YANCOPOULOS; George D. | 2019-08-15 |
| Methods of making a nucleic acid encoding a human variable region Grant 10,378,037 - Murphy , et al. A | 2019-08-13 |
| Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus Grant 10,378,039 - Murphy , et al. A | 2019-08-13 |
| Mice that produce hybrid antibodies Grant 10,378,040 - Murphy , et al. A | 2019-08-13 |
| Mice that produce hybrid antibodies Grant 10,378,038 - Murphy , et al. A | 2019-08-13 |
| Compositions and methods for modifying cells Grant 10,344,299 - Economides , et al. July 9, 2 | 2019-07-09 |
| Nuclease-mediated targeting with large targeting vectors Grant 10,301,646 - Frendewey , et al. | 2019-05-28 |
| Genetically modified mice and engraftment Grant 10,278,374 - Stevens , et al. | 2019-05-07 |
| Methods And Compositions For The Targeted Modification Of A Genome App 20190112619 - Frendewey; David ; et al. | 2019-04-18 |
| Isolating cells expressing secreted proteins Grant 10,261,093 - Fandl , et al. | 2019-04-16 |
| Methods of modifying eukaryotic cells Grant 10,227,625 - Murphy , et al. | 2019-03-12 |
| Methods and compositions for the targeted modification of a mouse embryonic stem cell genome Grant 10,208,317 - Frendewey , et al. Feb | 2019-02-19 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20190046609 - Yancopoulos; George D. | 2019-02-14 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20180339018 - Yancopoulos; George D. | 2018-11-29 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 10,130,681 - Yancopoulos November 20, 2 | 2018-11-20 |
| Genetically modified non-human animals and methods of use thereof Grant 10,123,518 - Herndler-Brandstetter , et al. November 13, 2 | 2018-11-13 |
| B Cell Lineage Based Immunogen Design With Humanized Animals App 20180298082 - Haynes; Barton ; et al. | 2018-10-18 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20180295820 - Herndler-Brandstetter; Dietmar ; et al. | 2018-10-18 |
| Markers Of Tumor Cell Response To Anti-cancer Therapy App 20180291468 - Frendewey; David ; et al. | 2018-10-11 |
| Markers of tumor cell response to anti-cancer therapy Grant 10,023,916 - Frendewey , et al. July 17, 2 | 2018-07-17 |
| Methods of Treating Inflammatory Conditions App 20180155436 - ORENGO; Jamie M. ; et al. | 2018-06-07 |
| Anti-activin A Antibodies And Uses Thereof App 20180155416 - Gromada; Jesper ; et al. | 2018-06-07 |
| Genetically modified non-human animals and methods of use thereof Grant 9,986,724 - Flavell , et al. June 5, 2 | 2018-06-05 |
| B cell lineage based immunogen design with humanized animals Grant 9,963,501 - Haynes , et al. May 8, 2 | 2018-05-08 |
| Genetically modified non-human animals and methods of use thereof Grant 9,901,082 - Flavell , et al. February 27, 2 | 2018-02-27 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20180049413 - Flavell; Richard ; et al. | 2018-02-22 |
| Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20180051066 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-02-22 |
| Nuclease-Mediated Targeting With Large Targeting Vectors App 20180037910 - Frendewey; David ; et al. | 2018-02-08 |
| Nuclease-mediated targeting with large targeting vectors Grant 9,834,786 - Frendewey , et al. December 5, 2 | 2017-12-05 |
| Humanized M-CSF Mice App 20170273285 - Murphy; Andrew J. ; et al. | 2017-09-28 |
| Multivalent Antigen-binding Proteins App 20170260293 - YANCOPOULOS; George D. ; et al. | 2017-09-14 |
| Compositions and Methods for Modifying Cells App 20170260544 - Economides; Aris N. ; et al. | 2017-09-14 |
| Multivalent Antigen-binding Proteins App 20170247474 - YANCOPOULOS; George D. ; et al. | 2017-08-31 |
| Isolating Cells Expressing Secreted Proteins App 20170241887 - Fandl; James P. ; et al. | 2017-08-24 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20170202911 - YANCOPOULOS; George D. | 2017-07-20 |
| Targeted Modification Of Rat Genome App 20170204430 - Lee; Jeffrey D. ; et al. | 2017-07-20 |
| Methods of making a nucleic acid encoding a human variable region Grant 9,708,635 - Murphy , et al. July 18, 2 | 2017-07-18 |
| Modified chimeric polypeptides with improved pharmacokinetic properties Grant 9,708,386 - Papadopoulos , et al. July 18, 2 | 2017-07-18 |
| Genetically Modified Mice And Engraftment App 20170172121 - Stevens; Sean ; et al. | 2017-06-22 |
| Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell Grant 9,677,129 - Economides , et al. June 13, 2 | 2017-06-13 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 9,669,069 - Yancopoulos June 6, 2 | 2017-06-06 |
| Humanized M-CSF mice Grant 9,655,352 - Murphy , et al. May 23, 2 | 2017-05-23 |
| Methods And Compositions For The Targeted Modification Of A Genome App 20170067078 - Frendewey; David ; et al. | 2017-03-09 |
| Genetically modified mice and engraftment Grant 9,554,563 - Stevens , et al. January 31, 2 | 2017-01-31 |
| Methods and compositions for the targeted modification of a mouse genome Grant 9,546,384 - Frendewey , et al. January 17, 2 | 2017-01-17 |
| Anti-PCSK9 antibodies with pH-dependent binding characteristics Grant 9,540,449 - Yancopoulos , et al. January 10, 2 | 2017-01-10 |
| Methods of modifying eukaryotic cells Grant 9,528,136 - Murphy , et al. December 27, 2 | 2016-12-27 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20160366862 - Flavell; Richard ; et al. | 2016-12-22 |
| Mice That Produce Hybrid Antibodies App 20160316731 - Murphy; Andrew J. ; et al. | 2016-11-03 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20160295844 - Herndler-Brandstetter; Dietmar ; et al. | 2016-10-13 |
| Diagnostic Tests And Methods For Assessing Safety, Efficacy Or Outcome Of Allergen-specific Immunotherapy (sit) App 20160223563 - YANCOPOULOS; George D. ; et al. | 2016-08-04 |
| Methods of producing hybrid antibodies Grant 9,388,446 - Murphy , et al. July 12, 2 | 2016-07-12 |
| Isolating cells expressing secreted proteins Grant 9,389,236 - Fandl , et al. July 12, 2 | 2016-07-12 |
| Methods of producing hybrid antibodies Grant 9,382,567 - Murphy , et al. July 5, 2 | 2016-07-05 |
| Methods of producing hybrid antibodies Grant 9,376,699 - Murphy , et al. June 28, 2 | 2016-06-28 |
| Genetically modified mice that produce hybrid antibodies Grant 9,371,553 - Murphy , et al. June 21, 2 | 2016-06-21 |
| Methods of producing hybrid antibodies Grant 9,353,394 - Murphy , et al. May 31, 2 | 2016-05-31 |
| Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas App 20160145646 - Frendewey; David ; et al. | 2016-05-26 |
| Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20160130320 - PAPADOPOULOS; Nicholas J. ; et al. | 2016-05-12 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20160101152 - YANCOPOULOS; George D. | 2016-04-14 |
| Genetically modified mice and engraftment Grant 9,301,509 - Stevens , et al. April 5, 2 | 2016-04-05 |
| Methods And Compositions For The Targeted Modification Of A Genome App 20160060657 - Frendewey; David ; et al. | 2016-03-03 |
| Use of a VEGF antagonist to treat angiogenic eye disorders Grant 9,254,338 - Yancopoulos February 9, 2 | 2016-02-09 |
| Isolating Cells Expressing Secreted Proteins App 20160033530 - FANDL; JAMES P. ; et al. | 2016-02-04 |
| Methods and compositions for the targeted modification of a genome Grant 9,228,208 - Frendewey , et al. January 5, 2 | 2016-01-05 |
| Mutivalent Antigen-binding Proteins App 20150203591 - Yancopoulos; George D. ; et al. | 2015-07-23 |
| Methods and Compositions for the Targeted Modification of a Genome App 20150159174 - Frendewey; David ; et al. | 2015-06-11 |
| Isolating Cells Expressing Secreted Proteins App 20150160215 - FANDL; JAMES P. ; et al. | 2015-06-11 |
| Methods And Compositions For The Targeted Modification Of A Genome App 20150159175 - Frendewey; David ; et al. | 2015-06-11 |
| Humanized M-CSF Mice App 20150047061 - Murphy; Andrew J. ; et al. | 2015-02-12 |
| Targeted Modification Of Rat Genome App 20140310828 - Lee; Jeffrey D. ; et al. | 2014-10-16 |
| Targeted Modification Of Rat Genome App 20140309487 - Lee; Jeffrey D. ; et al. | 2014-10-16 |
| Markers Of Tumor Cell Response To Anti-cancer Therapy App 20140308370 - Frendewey; David ; et al. | 2014-10-16 |
| Humanized M-CSF mice Grant 8,847,004 - Murphy , et al. September 30, 2 | 2014-09-30 |
| Method for genetically modifying isolated non-human mammalian cell by homologous recombination Grant 8,846,402 - Economides , et al. September 30, 2 | 2014-09-30 |
| B Cell Lineage Based Immunogen Design With Humanized Animals App 20140221625 - HAYNES; BARTON ; et al. | 2014-08-07 |
| Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse Grant 8,791,323 - Murphy , et al. July 29, 2 | 2014-07-29 |
| Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20140194597 - Papadopoulos; Nicholas J. ; et al. | 2014-07-10 |
| Compositions and Methods for Modifying Cells App 20140178879 - ECONOMIDES; ARIS N. ; et al. | 2014-06-26 |
| Method for genetically modifying mouse embryonic stem cell by homologous recombination Grant 8,759,105 - Economides , et al. June 24, 2 | 2014-06-24 |
| Genetically Modified Non-human Animals And Methods Of Use Thereof App 20140134662 - Flavell; Richard ; et al. | 2014-05-15 |
| Genetically modified mice and engraftment Grant 8,692,052 - Stevens , et al. April 8, 2 | 2014-04-08 |
| Genetically Modified Mice and Engraftment App 20140090095 - Stevens; Sean ; et al. | 2014-03-27 |
| Methods of Modifying Eukaryotic Cells App 20140073010 - MURPHY; ANDREW J. ; et al. | 2014-03-13 |
| Isolating Cells Expressing Secreted Proteins App 20140072979 - FANDL; JAMES P. ; et al. | 2014-03-13 |
| Isolating Cells Expressing Secreted Proteins App 20140072980 - FANDL; JAMES P. ; et al. | 2014-03-13 |
| ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS App 20140044730 - YANCOPOULOS; George D. ; et al. | 2014-02-13 |
| Methods for producing a fusion protein capable of binding VEGF Grant 8,647,842 - Papadopoulos , et al. February 11, 2 | 2014-02-11 |
| Methods of Modifying Eukaryotic Cells App 20140041068 - MURPHY; ANDREW J. ; et al. | 2014-02-06 |
| Methods of Modifying Eukaryotic Cells App 20140033336 - MURPHY; ANDREW J. ; et al. | 2014-01-30 |
| Methods of Modifying Eukaryotic Cells App 20140033337 - Murphy; Andrew J. ; et al. | 2014-01-30 |
| Methods of Modifying Eukaryotic Cells App 20140023637 - Murphy; Andrew J. ; et al. | 2014-01-23 |
| Methods of Modifying Eukaryotic Cells App 20140018522 - MURPHY; ANDREW J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140020124 - Murphy; Andrew J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140020125 - Murphy; Andrew J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140017781 - Murphy; Andrew J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140017238 - Murphy; Andrew J. ; et al. | 2014-01-16 |
| Isolating Cells Expressing Secreted Proteins App 20140017695 - FANDL; JAMES P. ; et al. | 2014-01-16 |
| Methods for Modifying Eukaryotic Cells App 20140017782 - Murphy; Andrew J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140017229 - MURPHY; ANDREW J. ; et al. | 2014-01-16 |
| Methods of Modifying Eukaryotic Cells App 20140013457 - Murphy; Andrew J. ; et al. | 2014-01-09 |
| Nuclease-Mediated Targeting With Large Targeting Vectors App 20130309670 - Frendewey; David ; et al. | 2013-11-21 |
| Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20130295094 - YANCOPOULOS; George D. | 2013-11-07 |
| Genetically modified mice and engraftment Grant 8,541,646 - Stevens , et al. September 24, 2 | 2013-09-24 |
| Methods of Modifying Eukaryotic Cells App 20130210137 - Murphy; Andrew J. ; et al. | 2013-08-15 |
| Methods of modifying eukaryotic cells Grant 8,502,018 - Murphy , et al. August 6, 2 | 2013-08-06 |
| Methods for Producing a Fusion Protein Capable of Binding VEGF App 20130149744 - Papadopoulos; Nicholas J. ; et al. | 2013-06-13 |
| Methods of Modifying Eukaryotic Cells App 20130137101 - Economides; Aris N. ; et al. | 2013-05-30 |
| Methods of Modifying Eurakyotic Cells App 20130130388 - Murphy; Andrew J. ; et al. | 2013-05-23 |
| IGF-1 fusion polypeptides and therapeutic uses thereof Grant 8,445,434 - Glass , et al. May 21, 2 | 2013-05-21 |
| Methods of using IL-1 antagonists to treat autoinflammatory disease Grant 8,414,876 - Mellis , et al. April 9, 2 | 2013-04-09 |
| Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide App 20130084635 - PAPADOPOULOS; Nicholas J. ; et al. | 2013-04-04 |
| Cell culture compositions capable of producing a VEGF-binding fusion polypeptide Grant 8,343,737 - Papadopoulos , et al. January 1, 2 | 2013-01-01 |
| Igf-1 Fusion Polypeptides And Therapeutic Uses Thereof App 20120195896 - GLASS; David J. ; et al. | 2012-08-02 |
| IGF-1 fusion polypeptides and therapeutic uses thereof Grant 8,158,581 - Glass , et al. April 17, 2 | 2012-04-17 |
| Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide App 20120064621 - Papadopoulos; Nicholas J. ; et al. | 2012-03-15 |
| Methods Of Using Il-1 Antagonists To Treat Autoinflammatory Disease App 20110318342 - Mellis; Scott ; et al. | 2011-12-29 |
| Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF Grant 8,084,234 - Papadopoulos , et al. December 27, 2 | 2011-12-27 |
| Methods Of Using Il-1 Antagonists To Treat Familial Mediterranean Fever (fmf) App 20110311537 - MELLIS; SCOTT ; et al. | 2011-12-22 |
| Methods of Modifying Eukaryotic Cells App 20110283376 - Murphy; Andrew J. ; et al. | 2011-11-17 |
| Methods of Modifying Eukaryotic Cells App 20110258710 - MURPHY; ANDREW J. ; et al. | 2011-10-20 |
| Modified chimeric polypeptides with improved pharmacokinetic properties Grant 8,029,791 - Papadopoulos , et al. October 4, 2 | 2011-10-04 |
| Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF Grant 7,964,377 - Papadopoulos , et al. June 21, 2 | 2011-06-21 |
| Receptor based antagonists and methods of making and using Grant 7,927,583 - Stahl , et al. April 19, 2 | 2011-04-19 |
| Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20110028698 - Papadopoulos; Nicholas J. ; et al. | 2011-02-03 |
| Igf-1 Fusion Polypeptides And Therapeutic Uses Thereof App 20110020342 - GLASS; DAVID J. ; et al. | 2011-01-27 |
| Method of increasing muscle mass with IGF-1 fusion polypeptides Grant 7,837,999 - Glass , et al. November 23, 2 | 2010-11-23 |
| Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20100221782 - Papadopoulos; Nicholas J. ; et al. | 2010-09-02 |
| Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides Grant 7,704,500 - Papadopoulos , et al. April 27, 2 | 2010-04-27 |
| Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20090155899 - Papadopoulos; Nicholas J. ; et al. | 2009-06-18 |
| Methods of Using IL-1 Antagonists to Treat Autoinflammatory Disease App 20090156492 - Mellis; Scott ; et al. | 2009-06-18 |
| Isolating Cells Expressing Secreted Proteins App 20090137416 - Fandl; James P. ; et al. | 2009-05-28 |
| Methods of treating diseases with a VEGF antagonist Grant 7,531,172 - Stahl , et al. May 12, 2 | 2009-05-12 |
| Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,524,499 - Papadopoulos , et al. April 28, 2 | 2009-04-28 |
| Use of VEGF inhibitors for treatment of eye disorders Grant 7,521,049 - Wiegand , et al. April 21, 2 | 2009-04-21 |
| Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20090081217 - Papadopoulos; Nicholas J. ; et al. | 2009-03-26 |
| IGF-1 Fusion Polypeptides and Therapeutic Uses Thereof App 20090069235 - GLASS; David J. ; et al. | 2009-03-12 |
| Methods of modifying eukaryotic cells App 20090055943 - Economides; Aris N. ; et al. | 2009-02-26 |
| Receptor Based Antagonists and Methods of Making and Using App 20090010879 - STAHL; Neil ; et al. | 2009-01-08 |
| Method for targeting transcriptionally active loci Grant 7,473,557 - Economides , et al. January 6, 2 | 2009-01-06 |
| Methods of using IL-1 antagonists to treat autoinflammatory disease Grant 7,459,426 - Mellis , et al. December 2, 2 | 2008-12-02 |
| Isolating cells expressing secreted proteins Grant 7,435,553 - Fandl , et al. October 14, 2 | 2008-10-14 |
| Use of VEGF inhibitors for treatment of eye disorders App 20080220004 - Wiegand; Stanley J. ; et al. | 2008-09-11 |
| IL-1 receptor based cytokine traps and method of using Grant 7,417,134 - Stahl , et al. August 26, 2 | 2008-08-26 |
| Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20080194799 - PAPADOPOULOS; Nicholas J. ; et al. | 2008-08-14 |
| Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties and Methods of Using Thereof App 20080194460 - PAPADOPOULOS; Nicholas J. ; et al. | 2008-08-14 |
| IGF-I fusion polypeptides and therapeutic uses thereof Grant 7,396,918 - Glass , et al. July 8, 2 | 2008-07-08 |
| Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof Grant 7,374,758 - Papadopoulos , et al. May 20, 2 | 2008-05-20 |
| Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,374,757 - Papadopoulos , et al. May 20, 2 | 2008-05-20 |
| Method of treating cancer with a VEGF antagonist and an anti-proliferative agent Grant 7,354,579 - Holash , et al. April 8, 2 | 2008-04-08 |
| Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) Grant 7,351,411 - Holash , et al. April 1, 2 | 2008-04-01 |
| Method of treatment using Tie2 ligand2 Grant 7,309,483 - Wiegand , et al. December 18, 2 | 2007-12-18 |
| Use of VEGF inhibitors for treatment of eye disorders Grant 7,306,799 - Wiegand , et al. December 11, 2 | 2007-12-11 |
| Methods of treating eye disorders with modified chimeric polypeptides Grant 7,303,746 - Wiegand , et al. December 4, 2 | 2007-12-04 |
| Use of VEGF inhibitors for treatment of eye disorders Grant 7,303,747 - Wiegand , et al. December 4, 2 | 2007-12-04 |
| Therapeutic method for treating bone formation diseases Grant 7,285,532 - Economides , et al. October 23, 2 | 2007-10-23 |
| Methods of modifying eukaryotic cells App 20070061900 - Murphy; Andrew J. ; et al. | 2007-03-15 |
| Methods of treating diseases with a VEGF antagonist App 20070037748 - Stahl; Neil ; et al. | 2007-02-15 |
| Isolating cells expressing secreted proteins App 20060234311 - Fandl; James P. ; et al. | 2006-10-19 |
| Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) App 20060210566 - Holash; Jocelyn ; et al. | 2006-09-21 |
| Methods of modifying eukaryotic cells Grant 7,105,348 - Murphy , et al. September 12, 2 | 2006-09-12 |
| High affinity fusion proteins and therapeutic and diagnostic methods for use Grant 7,083,950 - Stahl , et al. August 1, 2 | 2006-08-01 |
| Receptor based antagonists and methods of making and using Grant 7,083,949 - Stahl , et al. August 1, 2 | 2006-08-01 |
| IGF-I fusion polypeptides and therapeutic uses thereof App 20060166328 - Glass; David J. ; et al. | 2006-07-27 |
| Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,070,959 - Papadopoulos , et al. July 4, 2 | 2006-07-04 |
| Nucleic acid encoding TIE-2 ligand Grant 7,063,965 - Davis , et al. June 20, 2 | 2006-06-20 |
| TIE-2 ligands, methods of making and uses thereof Grant 7,063,840 - Davis , et al. June 20, 2 | 2006-06-20 |
| Expressed ligand-vascular intercellular signaling molecule Grant 7,045,302 - Davis , et al. May 16, 2 | 2006-05-16 |
| Methods of treating obesity with combination therapeutics App 20060058224 - Yancopoulos; George D. ; et al. | 2006-03-16 |
| Method of enhancing the biological activity of ligands Grant 7,008,781 - Davis , et al. March 7, 2 | 2006-03-07 |
| Use of VEGF inhibitors for treatment of eye disorders App 20060030529 - Wiegand; Stanley J. ; et al. | 2006-02-09 |
| Methods of inducing formation of functional and organized lymphatic vessels App 20060014204 - Gale; Nicholas W. ; et al. | 2006-01-19 |
| Methods of using IL-1 antagonists to treat autoinflammatory disease App 20050272655 - Mellis, Scott ; et al. | 2005-12-08 |
| Use of VEGF inhibitors for treatment of eye disorders App 20050260203 - Wiegand, Stanley J. ; et al. | 2005-11-24 |
| Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof App 20050245447 - Papadopoulos, Nicholas J. ; et al. | 2005-11-03 |
| Methods of imaging and targeting vasculature Grant 6,958,140 - Gale , et al. October 25, 2 | 2005-10-25 |
| Receptor based antagonists and methods of making and using App 20050222033 - Stahl, Neil ; et al. | 2005-10-06 |
| Expressed ligand - vascular intercellular signaling molecule App 20050186665 - Davis, Samuel ; et al. | 2005-08-25 |
| Isolating cells expressing secreted proteins App 20050186623 - Fandl, James P. ; et al. | 2005-08-25 |
| Tie-2 ligands, methods of making and uses thereof App 20050175617 - Wiegand, Stanley J. ; et al. | 2005-08-11 |
| Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof App 20050175610 - Wiegand, Stanley J. ; et al. | 2005-08-11 |
| IL-1 receptor based cytokine traps Grant 6,927,044 - Stahl , et al. August 9, 2 | 2005-08-09 |
| Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof App 20050163798 - Papadopoulos, Nicholas J. ; et al. | 2005-07-28 |
| Isolating cells expressing secreted proteins Grant 6,919,183 - Fandl , et al. July 19, 2 | 2005-07-19 |
| Methods of modifying eukaryotic cells App 20050144655 - Economides, Aris N. ; et al. | 2005-06-30 |
| Methods of stimulating cartilage formation Grant 6,908,744 - DeChiara , et al. June 21, 2 | 2005-06-21 |
| Method for targeting transcriptionally active loci App 20050120401 - Economides, Aris N. ; et al. | 2005-06-02 |
| Expressed ligand-vascular intercellular signaling molecule App 20050106099 - Davis, Samuel ; et al. | 2005-05-19 |
| TIE-2 ligands, methods of making and uses thereof App 20050100906 - Davis, Samuel ; et al. | 2005-05-12 |
| TIE-2 ligand-4 Grant 6,881,395 - Valenzuela , et al. April 19, 2 | 2005-04-19 |
| High affinity fusion proteins and therapeutic and diagnostic methods for use App 20050074855 - Stahl, Neil ; et al. | 2005-04-07 |
| High affinity fusion proteins and therapeutic and diagnostic methods for use App 20050032175 - Stahl, Neil ; et al. | 2005-02-10 |
| Composition of a VEGF antagonist and an anti-proliferative agent App 20050032699 - Holash, Jocelyn ; et al. | 2005-02-10 |
| Tyrosine kinase receptors and ligands Grant 6,852,838 - Valenzuela , et al. February 8, 2 | 2005-02-08 |
| Tie-2 ligand-3 Grant 6,846,914 - Valenzuela , et al. January 25, 2 | 2005-01-25 |
| Methods of treating inflammatory skin diseases App 20040266686 - Xia, Yuping ; et al. | 2004-12-30 |
| Methods of treating inflammatory skin diseases Grant 6,833,349 - Xia , et al. December 21, 2 | 2004-12-21 |
| Expressed ligand--vascular intercellular signalling molecule Grant 6,825,008 - Davis , et al. November 30, 2 | 2004-11-30 |
| Prevention of retinal injury and degeneration by specific factors App 20040171529 - LaVail, Matthew ; et al. | 2004-09-02 |
| Prevention of retinal injury and degeneration by specific factors Grant 6,780,837 - LaVail , et al. August 24, 2 | 2004-08-24 |
| Therapeutic method for treating bone formation diseases App 20040132661 - Economides, Aris N. ; et al. | 2004-07-08 |
| Methods of isolation of active compounds and activated targets App 20040086946 - Murphy, Andrew J. ; et al. | 2004-05-06 |
| Methods of inducing formation of functional and organized lymphatic vessels App 20040023880 - Gale, Nicholas W. ; et al. | 2004-02-05 |
| Methods of modifying eukaryotic cells App 20040018626 - Murphy, Andrew J. ; et al. | 2004-01-29 |
| Biologically active Eph family ligands App 20030215918 - Davis, Samuel ; et al. | 2003-11-20 |
| Method of blocking blood vessel growth using tie-2 ligand 2 Grant 6,645,484 - Davis , et al. November 11, 2 | 2003-11-11 |
| TIE-2 ligands, methods of making and uses thereof Grant 6,627,415 - Davis , et al. September 30, 2 | 2003-09-30 |
| TIE-2 ligands, methods of making and uses thereof App 20030166858 - Davis, Samuel ; et al. | 2003-09-04 |
| TIE-2 ligands, methods of making and uses thereof App 20030166857 - Davis, Samuel ; et al. | 2003-09-04 |
| Biologically active Eph family ligands Grant 6,602,683 - Davis , et al. August 5, 2 | 2003-08-05 |
| Receptor based antagonists and methods of making and using App 20030143697 - Stahl, Neil ; et al. | 2003-07-31 |
| Methods of modifying eukaryotic cells Grant 6,596,541 - Murphy , et al. July 22, 2 | 2003-07-22 |
| Methods of modifying eukaryotic cells Grant 6,586,251 - Economides , et al. July 1, 2 | 2003-07-01 |
| TIE-2 ligands, methods of making and uses thereof App 20030109677 - Davis, Samuel ; et al. | 2003-06-12 |
| Receptor based antagonists and methods of making and using App 20030104567 - Stahl, Neil ; et al. | 2003-06-05 |
| Expressed ligand - vascular intercellular signalling molecule App 20030092891 - Davis, Samuel ; et al. | 2003-05-15 |
| Methods of expressing transgenes App 20030084468 - Economides, Aris N. ; et al. | 2003-05-01 |
| Novel ligands, methods of making and uses thereof App 20030064470 - Valenzuela, David M. ; et al. | 2003-04-03 |
| Novel ligands, methods of making and uses thereof App 20030059887 - Valenzuela, David M. ; et al. | 2003-03-27 |
| TIE-2 ligands, methods of making and uses thereof App 20030040463 - Wiegand, Stanley J. ; et al. | 2003-02-27 |
| Methods of treating inflammatory skin diseases App 20030017977 - Xia, Yuping ; et al. | 2003-01-23 |
| Method for targeting transcriptionally active loci App 20030003581 - Economides, Aris N. ; et al. | 2003-01-02 |
| Methods of modifying eukaryotic cells App 20020183275 - Murphy, Andrew J. ; et al. | 2002-12-05 |
| TIE-2 ligands, methods of making and uses thereof App 20020173627 - Davis, Samuel ; et al. | 2002-11-21 |
| Isolating cells expressing secreted proteins App 20020168702 - Fandl, James P. ; et al. | 2002-11-14 |
| Novel tyrosine kinase receptors and ligands App 20020164702 - Valenzuela, David M. ; et al. | 2002-11-07 |
| Receptor based antagonists and methods of making and using Grant 6,472,179 - Stahl , et al. October 29, 2 | 2002-10-29 |
| Angiopoietins and methods of use thereof Grant 6,455,035 - Suri , et al. September 24, 2 | 2002-09-24 |
| Methods of imaging and targeting vasculature App 20020119097 - Gale, Nicholas W. ; et al. | 2002-08-29 |
| Expressed ligand-vascular intercellular signalling molecule Grant 6,441,137 - Davis , et al. August 27, 2 | 2002-08-27 |
| Tie-2 ligands Grant 6,433,143 - Davis , et al. August 13, 2 | 2002-08-13 |
| Methods of modifying eukaryotic cells App 20020106629 - Murphy, Andrew J. ; et al. | 2002-08-08 |
| Methods of modifying eukaryotic cells App 20020106628 - Economides, Aris N. ; et al. | 2002-08-08 |
| Dorsal tissue affecting factor and compositions App 20020102643 - Valenzuela, David M. ; et al. | 2002-08-01 |
| Assay systems for leptin-enhancing agents App 20020012949 - Carpenter, Laura R. ; et al. | 2002-01-31 |
| Receptor Based Antagonists And Methods Of Making And Using App 20020012962 - STAHL, NEIL ; et al. | 2002-01-31 |
| Chimeric molecules and novel assay system App 20010044135 - Stahi, Neil ; et al. | 2001-11-22 |
| ERK3 MAP2 protein kinase Grant 6,303,358 - Boulton , et al. October 16, 2 | 2001-10-16 |
| ERK1 MAP2 protein kinase Grant 6,297,035 - Boulton , et al. October 2, 2 | 2001-10-02 |
| Expressed ligand-vascular intercellular signalling molecule Grant 6,265,564 - Davis , et al. July 24, 2 | 2001-07-24 |
| Antibodies to human TIE-2 ligands Grant 6,166,185 - Davis , et al. December 26, 2 | 2000-12-26 |
| Family of MAP2 protein kinases Grant 5,914,261 - Boulton , et al. June 22, 1 | 1999-06-22 |
| Tie-2 ligand 1 Grant 5,879,672 - Davis , et al. March 9, 1 | 1999-03-09 |
| Family of MAP2 protein kinases Grant 5,872,006 - Boulton , et al. February 16, 1 | 1999-02-16 |
| Tie ligand-3, methods of making and uses thereof Grant 5,851,797 - Valenzuela , et al. December 22, 1 | 1998-12-22 |
| Ehk and Ror tyrosine kinases Grant 5,843,749 - Maisonpierre , et al. December 1, 1 | 1998-12-01 |
| Cytokine antagonists Grant 5,844,099 - Stahl , et al. December 1, 1 | 1998-12-01 |
| Hybridoma cell lines and antibodies that bind noggin Grant 5,821,124 - Valenzuela , et al. October 13, 1 | 1998-10-13 |
| Tyrosine kinase receptors and ligands Grant 5,814,478 - Valenzuela , et al. September 29, 1 | 1998-09-29 |
| Nucleic acids encoding TIE-2 ligand-2 Grant 5,814,464 - Davis , et al. September 29, 1 | 1998-09-29 |
| Family of MAP2 protein kinases Grant 5,776,751 - Boulton , et al. July 7, 1 | 1998-07-07 |
| Method of enhancing the biological activity of Eph family ligands Grant 5,747,033 - Davis , et al. May 5, 1 | 1998-05-05 |
| Prevention of retinal injury and degeneration by specific factors Grant 5,667,968 - LaVail , et al. September 16, 1 | 1997-09-16 |
| Tie-2 ligand 2 Grant 5,650,490 - Davis , et al. July 22, 1 | 1997-07-22 |
| Nucleic acid encoding tie-2 ligand Grant 5,643,755 - Davis , et al. July 1, 1 | 1997-07-01 |
| Family of map2 protein kinases Grant 5,595,904 - Boulton , et al. January 21, 1 | 1997-01-21 |
| TIE-2 ligand, and method of making Grant 5,521,073 - Davis , et al. May 28, 1 | 1996-05-28 |
| CNTF and IL-6 antagonists Grant 5,470,952 - Stahl , et al. November 28, 1 | 1995-11-28 |
| Prevention of ES cell differentiation by ciliary neurotrophic factor Grant 5,332,672 - Conover , et al. July 26, 1 | 1994-07-26 |
| Mammalian expression vector Grant 5,266,490 - Davis , et al. November 30, 1 | 1993-11-30 |
| Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras Grant 5,169,764 - Shooter , et al. December 8, 1 | 1992-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 